House Bill 1959
2021-2022 Regular Session
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Co-Sponsorship Memo
Prime Sponsor
Representative Tracy Pennycuick
R House District 147
Co-Sponsors
Rep. Jennifer O'Mara
D House District 165
Rep. MaryLouise Isaacson
D House District 175
Rep. Tina Davis
D House District 141
Rep. Michael Schlossberg
D House District 132
Rep. Tim Hennessey
R House District 26
Rep. Carrie Lewis DelRosso
R House District 33
Rep. Nancy Guenst
D House District 152
Rep. F. Todd Polinchock
R House District 144
Rep. Matthew Dowling
R House District 51
Rep. Joe Hamm
R House District 84
Rep. Benjamin Sanchez
D House District 153
Rep. Christina Sappey
D House District 158
Rep. Brian Sims
D House District 182
Rep. Timothy J. O'Neal
R House District 48
Rep. Melissa Shusterman
D House District 157
Rep. Karen Boback
R House District 117
Rep. Napoleon J. Nelson
D House District 154
Rep. Aaron Bernstine
R House District 10
Rep. Eric Nelson
R House District 57
Rep. Jeanne McNeill
D House District 133
Rep. Mary Jo Daley
D House District 148
Rep. Christopher Quinn
R House District 168
Rep. Greg Rothman
R House District 87
Rep. P. Sturla
D House District 96
Bill Status & History
Last Action: Referred to Health, Oct. 12, 2021
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Statute References
There are no statute references for this bill.
House Bill 1959
2021-2022 Regular Session
Sponsors
PENNYCUICK, O'MARA, ISAACSON, T. DAVIS, SCHLOSSBERG, HENNESSEY, LEWIS DELROSSO, GUENST, POLINCHOCK, DOWLING, HAMM, SANCHEZ, SAPPEY, SIMS, O'NEAL, SHUSTERMAN, BOBACK, N. NELSON, BERNSTINE, E. NELSON, McNEILL, DALEY, QUINN, ROTHMAN, STURLA
Short Title
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Memo Subject
REVISED - Public Health Benefits of Psilocybin Act
Actions
| 2260 | Referred to HEALTH, Oct. 12, 2021 |
Generated 04/21/2025 06:04 PM